Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Good
|
New words:
abetted, ACA, ACE, acquiror, activist, aided, allegedly, amber, Amigaltm, Anchen, andRule, ATAP, auditor, beholden, Bernard, bioequivalence, biology, black, box, BTG, budget, budgetary, calendar, Canute, Canutejoined, capitalizable, capture, Carlo, Chester, Cholestageltm, Coast, Codificationtm, competitor, compound, compounded, constitute, converge, cut, Daiichi, debate, Deliverable, density, Deval, DF, digit, divestiture, donut, ease, electrical, Eli, Emanuel, Endocrinology, enjoining, entrepreneurial, entry, ERP, error, Evoltratm, evolving, excise, expert, explicitly, exploratory, faith, Frameworkissued, fundamental, fundamentally, gap, German, gland, globe, Goldman, Governor, Greece, Greek, Guarantor, Guard, HCERA, heard, HemOnc, HGT, hole, Hospira, HRSA, ICIG, IMF, improperly, infrastructure, inhibit, inIn, injunctive, inquiry, insert, insignificant, insignificantly, intermediate, isIn, Italy, Jerry, Jonexatm, Kahn, lapse, lattice, leadership, lieu, Lilly, lipoprotein, Litigationand, Louisiana, MabCampathtm, MACItm, Malina, membrane, Mena, merge, metric, mid, Middlesex, misleadingSchedule, modification, Monte, Moscickibecame, nonprofit, onForm, onSchedule, opposition, overview, Parent, Patrick, payout, peer, perpetual, PGH, phone, Pinchuck, Police, polyallylamine, postoperative, PPACA, predetermined, preexisting, promptly, proper, PSU, punitive, qualitative, Quantic, Racketeer, randomly, rank, recast, refrain, renovate, repayment, repeal, reply, rescinding, retention, Revocable, routinely, sachet, Sanofi, satisfactorily, scheme, Sekisui, seller, Session, Shade, shift, simulation, SKI, slightly, Smithjoined, Southeast, Spain, SRI, sublicensee, subset, sued, Suffolk, Sunshine, teaching, Teijin, thereon, theSchedule, thisForm, thwart, tied, tradable, twenty, unanimously, uncertainty, unconditional, unconditionally, underestimated, unfilled, unfinished, unique, UPLYSO, UPLYSOtm, Veteran, vi, viscosupplement, vitroandin, vivopreclinical, VPRIV, VPRIVtm, Wall, Warren, water, Watson, William, Wirthjoined, withdrawn
Removed:
AB, absorbed, absorption, accumulation, accurate, acetate, acid, Actelion, Adept, advisory, aimed, aluminum, Amgen, Amigal, Analyte, Anika, Argentina, Arranon, Artz, ASR, bacterial, banking, Bard, Baxter, bendamustine, Biogen, brand, calcification, Calcijex, calcimimetic, calcium, cardiac, chaperone, Chile, concentrated, cytarabine, Davol, deficiency, deficient, dementia, destruction, deterioration, Diego, directive, divided, document, Durolane, effectuated, enable, enlargement, epratuzamab, Ethicon, Euflexxa, exempt, exhibit, family, fatty, Fe, fermentation, Ferring, Fidia, filling, formalized, function, Genentech, GlucaTex, glucocerebrosidase, GlyPro, harmful, hernia, Hurler, Hyalgan, hyaluronan, hyaluronic, hydroxide, Hylaform, Hylashield, hypercalcemia, hypothyroid, hypothyroidism, Idec, immunosuppressive, incorporating, indemnification, informally, infrequently, InSight, intestinal, IP, Israel, IUO, IVD, Jersey, Kogyo, lanthanum, laparoscopic, lenalidomide, liquid, liver, LongSAGE, lumiliximab, lymphocytic, Lymphoglobuline, MabCampath, MabThera, magnesium, Maidstone, Malling, MDS, medication, mesh, mild, mitoxantrone, moderate, morbidity, mortality, muscle, mutually, myelodysplastic, nelarabine, Nephew, Nite, notification, obligate, ofatumumab, Orthovisc, OSOM, osteomalacia, parathyroid, paricalcitol, pharmacological, physical, predictive, premature, privately, progressed, progression, protocol, PTH, radioiodine, rapidly, recurrent, registering, relentlessly, replace, replacing, requested, residual, resolve, resolved, responded, rest, Ridgefield, Rituxan, Roche, RUO, SAGE, Santa, Scheie, screened, Seikagaku, solution, South, spectrum, SPHERE, spleen, strong, structured, suffering, Supartz, Teva, TitleHenri, tract, typical, unaware, undergoing, unsuitable, untapped, untreated, variation, virtually, vitro, vivo, Zavesca
Filing tables
Filing exhibits
GZTR similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (File Nos. 33-61853, 333-51790, 333-63802, 333-109179) and in the Registration Statements on Form S-8 (File Nos. 33-58359, 33-60437, 333-10003, 333-33249, 333-83677, 333-51906, 33-30007, 33-68208, 333-33265, 333-10005, 333-33251, 333-83669, 333-33291, 33-21241, 333-55126, 333-42371, 333-81275, 333-87967, 333-81277, 333-83673, 333-64103, 333-83681, 333-51872, 333-52202, 333-66130, 333-70310, 333-76762, 333-76766, 333-76768, 333-76770, 333-100722, 333-90514, 333-90512, 333-90510, 333-64095, 333-106691, 333-106692, 333-111314, 333-116650, 333-116651, 333-116653, 333-114184, 333-125723, 333-125724, 333-125726, 333-139491, 333-139492, 333-143467, 333-143468, 333-143469, 333-153898, 333-160397, 333-160398, 333-165604, 333-167871, 333-167872, 333-167873) of Genzyme Corporation of our report dated March 1, 2011 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in the Annual Report to Shareholders, which is incorporated in this Form 10-K.
/s/PricewaterhouseCoopers LLP
Boston, Massachusetts
March 1, 2011
March 1, 2011